A phase I/II study of a tetanus vaccine booster to prime the immune system prior to administration of a therapeutic vaccine in patients with lethal Glioblastoma multiforme (GBM) brain tumours
Phase of Trial: Phase I/II
Latest Information Update: 10 Apr 2015
At a glance
- Drugs PEPIDH1M (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 10 Apr 2015 New trial record
- 12 Mar 2015 According to an Annias Immunotherapeutics media release, data from this study were presented in Nature.
- 12 Mar 2015 Pooled results from this and one other study (see CTP 700255629) were published in an Annias Immunotherapeutics Media Release.